title: Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.
authors.forename: C
authors.initials: C
authors.lastname: Kapitza
authors.forename: K
authors.initials: K
authors.lastname: Rave
authors.forename: K
authors.initials: K
authors.lastname: Ostrowski
authors.forename: T
authors.initials: T
authors.lastname: Heise
authors.forename: L
authors.initials: L
authors.lastname: Heinemann
mesh_terms: D000368:Aged; D061265:Biphasic Insulins; D001786:Blood Glucose / Q000378:metabolism*; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D061267:Insulin Aspart; D007336:Insulin, Isophane; D008297:Male; D008875:Middle Aged; D019518:Postprandial Period
chemical_list: D061265:Biphasic Insulins; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; C557564:insulin aspart, insulin aspart protamine drug combination 30:70; D007336:Insulin, Isophane; D061267:Insulin Aspart